Stone Pharmaceutical Group: purchase about HK $49.18 million of shares under the share incentive scheme

[stone Pharmaceutical Group: purchasing about HK $49.18 million shares under the share Award Scheme] 01093.HK issued an announcement that on that day, the trustees of the scheme purchased a total of 7 million shares in the company in the market in accordance with the terms and conditions of the scheme and held them in trust for the benefit of the selected participants (as defined in the scheme). The average consideration per share is about HK $7.026, at a cost of about HK $49.18 million.